Cite
MLA Citation
A Kavanaugh et al.. “SAT0446 Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and previous inadequate response to tumour necrosis factor-inhibitors.” Annals of the rheumatic diseases, vol. 76, n.d., p. 941. http://access.bl.uk/ark:/81055/vdc_100135139345.0x000063